Search

Author/Creator Schmaljohn, C.

1. A Phase 1 clinical trial of Hantaan virus and Puumala virus M‐segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. (7th March 2014)

Authors:
Hooper, J. W.; Moon, J. E.; Paolino, K. M.; Newcomer, R.; McLain, D. E.; Josleyn, M.; Hannaman, D.; Schmaljohn, C.
Journal:
Clinical microbiology and infection
Issue:
Volume 20(2014)Supplement 5
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The pathogenesis of genetically diverse strains of Crimean-Congo hemorrhagic fever virus in the cynomolgus macaque model. (February 2019)

Authors:
Smith, D.; Shoemaker, C.J.; Garrison, A.; Ricks, K.M.; Flusin, O.; Voorhees, M.; Zelko, J.; Kimmel, A.; Koehler, J.; Golden, J.; Pratt, W.; Fitzpatrick, C.; Shamblin, J.; Rossi, F.; Schoepp, R.; Schmaljohn, C.
Journal:
International journal of infectious diseases
Issue:
Volume 79(2019)Supplement 1
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗